Private Equity Hub -- Hawaii Biotech Inc., an Aiea, Hawaii-based vaccine maker, has filed for Chapter 11 bankruptcy protection. The company plans to continue its human clinical trials, which include development of vaccines to protect against West Nile virus, dengue fever and tick-borne encephalitis.
